ARCHIVES

Zaltrap Price Cut In Half Effective Immediately

This article is from The Cancer Letter archive.

Vol. 38 No. 42 | November 8, 2012

Download PDF Visit The Full Archive

Related Articles

New Cancer Survival, Incidence, Mortality Statistics Cause for Optimism, Concern

February 12, 1988

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

In Brief: ACS Awards Three More Grants For Prevention Research; AHF Establishes Chair In Nutrition

November 14, 1980

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009